Sequence variability and candidate gene analysis in complex disease: Association of μ opioid receptor gene variation with substance dependence

Human Molecular Genetics

Volumn 9, Issue 19, 2000, Pages 2895-2908

  Hoehe, Margret R ^a,b,e   Köpke, Karla ^a,b   Wendel, Birgit ^a   Rohde, Klaus ^a   Flachmeier, Christina ^a   Kidd, Kenneth K ^c   Berrettini, Wade H ^d   Church, George M ^e  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b GenProfile AG   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; COCAINE; DIAMORPHINE; DNA; GUANINE; HLA DQ ANTIGEN; MU OPIATE RECEPTOR; THYMINE;

ADULT; ARTICLE; CLUSTER ANALYSIS; COCAINE DEPENDENCE; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC DIFFERENCE; GENE CLUSTER; GENE SEQUENCE; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE DRUG ABUSE; NEGRO; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION RISK; PRIORITY JOURNAL; RECEPTOR GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU; SEQUENCE ANALYSIS, DNA; SUBSTANCE-RELATED DISORDERS; VARIATION (GENETICS);

EID: 0034703870     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Positional cloning moves from perditional to traditional
2. Variations on a theme: Cataloging human DNA sequence variation
3. The future of genetic studies of complex human diseases
4. The new genomics: Global views of biology
5. It's raining SNPs, hallelujah?
6. DNA sequence diversity in a 9.7 kb region of the human lipoprotein lipase gene
7. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study
8. Allelic diversity of the human plasma α-(1,3) fucosyl-transferase gene (FUT6)
9. Polymorphisms in the human DNA repair gene XPF
10. Genetic variability of the human mu opioid receptor gene and its implication for substance abuse
11. Sequence variation in the human angiotensin converting enzyme
12. Is there a paradigm shift in genetics? Lessons from the study of human diseases
13. Linkage disequilibrium mapping of complex disease: Fantasy or reality?
14. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase
15. Genetics of disease. Complex genetics, complex diseases
16. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
17. Opioids: First lessons from knockout mice
18. Dosedependent influence of fentanyl on prolactin, growth hormone, and mood
19. Opiates, opioids and addiction
20. Endogenous opioid systems and alcohol addiction
21. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains
22. Genetic dissection of complex traits
23. The human mu opioid receptor gene: 5' regulatory and intronic sequences
24. Multiplex DNA sequencing
25. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse
26. Mu opioid receptor gene variants: Lack of association with alcohol dependence
27. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction
28. The human mu opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C
29. An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA
30. Conversion of diploidy to haploidy
31. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila
32. Application of cladistics to the analysis of genotype-phenotype relationships
33. Detecting disease-predisposing variants: The haplotype method
34. The neighbor-joining method: A new method for reconstructing phylogenetic trees
35. An overview of combinatorial data analysis
36. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus
37. Cladistic approaches to identifying determinants of variability in multifactorial phenotypes and the evolutionary significance of variation in the human genome
38. Issues and strategies in the genetic analysis of alcoholism and related addictive behaviors
39. Associations of disease with genetic markers: Deja vu all over again
40. Genetic association study in psychiatry: Analytical evaluation and a recommendation
41. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans
42. Population frequencies of the A1 allele at the dopamine D2 receptor locus
43. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism
44. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins
45. The μ opiate receptor as candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses
46. The effects of repeated morphine exposure on μ opioid receptor number and affinity in C57BL/6J and DBA/2J mice
47. Increased μ opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving
48. Naltrexone in the treatment of alcohol dependence
49. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
50. Blindness and reliability in lifetime psychiatric diagnosis
51. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
52. DNA sequencing with direct transfer electrophoresis and nonradioactive detection
53. Human μ-opioid receptor variation and alcohol dependence
54. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population
55. HAPLO: A program using the EM algorithm to estimate the frequencies of multi-site haplotypes
56. Relative efficiencies of the maximum likelihood, maximum parsimony, and neighbor-joining methods for estimating protein phylogeny
57. Exact inference for contingency-tables with ordered categories
58. A network algorithm for performing Fisher's exact test in r X c contingency tables
59. A hybrid algorithm for Fisher's exact test on unordered r X c contingency tables
60. FEXACT: A FORTRAN subroutine for Fisher's exact test on unordered r X c contingency tables
61. Human μ opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment
62. Structure and expression of HLA-DQ alpha and -DX alpha genes: Interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector
63. Recommendations for a nomenclature system for human gene mutations
64. Mutation nomenclature: Nicknames, systematic names and unique indentifiers
65. Update on nomenclature for human gene mutations